4//SEC Filing
Cline Darren S 4
Accession 0000950170-25-089721
CIK 0001582313other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 9:35 PM ET
Size
5.2 KB
Accession
0000950170-25-089721
Insider Transaction Report
Form 4
Cline Darren S
Chief Commercial Officer
Transactions
- Award
Share Option (Right to Buy)
2025-06-23+185,800→ 185,800 totalExercise: $31.49Exp: 2035-06-22→ Common Shares (185,800 underlying)
Footnotes (1)
- [F1]Vesting 25% on June 23, 2026, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001633639
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 9:35 PM ET
- Size
- 5.2 KB